Connection

Stefano Rusconi to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Stefano Rusconi has written about HIV Integrase Inhibitors.
Stefano Rusconi
Connection Strength
0.369
HIV Integrase Inhibitors
  1. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting. J Antimicrob Chemother. 2019 05 01; 74(5):1363-1367.
    View in: PubMed
    Score: 0.169
  2. Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects. HIV Clin Trials. 2018 12; 19(6):242-248.
    View in: PubMed
    Score: 0.164
  3. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS. 2017 01 28; 31(3):455-457.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.